Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Pro-inflammatory exposures from food" is not a specific molecule, receptor, or canonical therapeutic target. Instead, it refers to **dietary patterns or specific foods that promote chronic inflammation in the body**. These pro-inflammatory effects are mediated through complex interactions between nutrients, gut microbiota composition and function, immune cell activation, and metabolic pathways. Key features include: • **Dietary patterns high in processed foods, animal-derived products, saturated fats, sugar, salt**, and low in fiber are associated with increased levels of pro-inflammatory markers such as CRP and IL‑6[3][5]. • Such diets can alter the gut microbiome toward a state that promotes intestinal inflammation by increasing pathobionts and endotoxin synthesis pathways; this can activate immune receptors like toll-like receptor 4 on immune cells leading to upregulation of NF‑κB signaling—a central pathway for inflammation[3][5]. • The empirical dietary inflammatory pattern (EDIP) is a validated scoring system used in research to quantify the inflammatory potential of an individual's diet based on their intake of various food groups correlated with plasma biomarkers like CRP and IL‑6[1]. • Chronic exposure to pro-inflammatory diets has been linked epidemiologically to higher risks for diseases such as certain cancers—including breast cancer—cardiovascular disease, diabetes/metabolic syndrome,[1][3] as well as exacerbation of autoimmune conditions. • There are no drugs that "target" these exposures directly; rather interventions focus on modifying dietary habits toward anti-inflammatory patterns rich in plant-based foods, healthy fats like omega‑3 fatty acids from fish or nuts,[2] antioxidants from fruits/vegetables,[4] whole grains,[6] etc. Because "pro-inflammatory exposures from food" does not refer to a discrete molecular entity but rather a set of environmental/lifestyle factors influencing biological processes through multiple indirect mechanisms—it should not be considered a canonical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pro-inflammatory exposures from food.